news

News

NEWS RELEASE

Propagator’s Living With platform selected as one of the leading high potential health innovators

September 2017: Living With selected by DigitalHealth.London to participate in second Accelerator programme, an achievement awarded to 30 of the leading high potential health tech innovators.

With is a long-term condition management platform for healthcare professionals to monitor patients’ real-time adherence and disease activity and early warning system that helps clinicians optimise resource, identify the most effective interventions with an aim at preventing symptoms from escalating requiring more expensive treatments.

Initially focused on women’s health and auto-immune conditions, Living With’s first two products are Living With Pelvic Health and Living With Rheumatoid Arthritis. Living With Pelvic Health will launch at the annual Pelvic, Obstetric and Gynaecological Physiotherapy (POGP) conference 6 October 2017 in Southampton.

“We’re thrilled that our Living With platform has been selected as one of the leading high potential health tech innovators in the UK. It’s an honour to participate and work alongside some really fantastic people who are trying to make innovation and digital care accessible through the NHS”, Living With co-founder Chris Robson commented.

The DigitalHealth.London Accelerator is the first major programme of DigitalHealth.London. The programme is for digital health businesses that would benefit from better engagement with the NHS and the wider health sector, in order to refine and develop products and services that meet the needs of the system.

DigitalHealth.London was launched in 2016, following a recommendation by Lord Darzi and the London Health Commission. The programme benefits from a collaboration between the three London Academic Health Science Networks (AHSNs): the Health Innovation Network (HIN), Imperial College Health Partners, UCLPartners, plus MedCity, CW+, the Mayor of London and NHS England. It is supported by Guy’s and St Thomas’ Charity and is part-funded by the European Regional Development Fund.